Characterizing Tumor-Induced Ataxia in a Vestibular Schwannoma Mouse Model

Area of Science:

• Neuroscience
• Genetics
• Oncology

Background:

• NF2-related schwannomatosis (NF2-SWN) is a genetic disorder caused by NF2 gene mutations, leading to tumors like vestibular schwannomas (VSs).
• VSs cause hearing loss, imbalance, and ataxia, significantly impacting patient quality of life, with no current pharmacologic treatments.
• Ataxia is a debilitating symptom of NF2-SWN that is understudied due to a lack of effective preclinical models.

Purpose of the Study:

• To develop and validate a set of behavioral assays for systematically assessing tumor-induced ataxia in a mouse model.
• To establish a preclinical platform for evaluating therapeutic strategies targeting ataxia in NF2-SWN.
• To enable mechanistic studies of cerebellar dysfunction and characterize treatment effects on tumor suppression and neuroprotection.

Main Methods:

• Developed an orthotopic mouse model of VS-associated hearing loss and ataxia.
• Implemented a suite of quantitative behavioral assays to measure balance and motor coordination deficits.
• Integrated behavioral assessments with tumor biology and hearing tests for comprehensive evaluation.

Main Results:

• Successfully established a preclinical platform for evaluating tumor-induced ataxia.
• Demonstrated the utility of behavioral assays in quantifying motor deficits.
• Facilitated the characterization of potential therapeutic interventions.

Conclusions:

• The developed behavioral assays provide a robust tool for studying ataxia in NF2-SWN.
• This experimental platform supports the preclinical evaluation of novel therapeutic strategies.
• The assays are adaptable for studying ataxia in other neurological disorders.